The advantages of European populations in GWA studies suggest that Europeans might productively be used for finding risk variants in non-Europeans. However, European populations contain only a subset of human genetic variation. Populations vary in terms of allele frequencies, biological adaptations, and other properties that affect the detectability and importance of risk variants, and several observations suggest that no single population is sufficient for fully uncovering the variants underlying disease in all populations.
